hellotayssir/FinQA_TAT-QA_financial_finetuning_dataset huggingface dataset:
RESULTS FROM VESSEL OPERATIONS
During the year ended December 31, 2019, shipping revenues decreased by $10,616 or 2.9% compared to 2018. The decrease primarily resulted from three fewer vessels in operation during most of 2019 compared to 2018 and one less Government of Israel voyage in 2019 compared to 2018. This decrease was partially offset by the addition of two new vessels to our fleet at the beginning of the fourth quarter of 2019.
Reconciliations of TCE revenues, a non-GAAP measure, to shipping revenues as reported in the consolidated statements of operations follows:
Consistent with general practice in the shipping industry, we use TCE revenues, which represents shipping revenues less voyage expenses, as a measure to compare revenue generated from a voyage charter to revenue generated from a time charter.
TCE revenues, a non-GAAP measure, provides additional meaningful information in conjunction with shipping revenues, the most directly comparable GAAP measure, because it assists management in decisions regarding the deployment and use of our vessels and in evaluating their financial performance.
Table:
 | Years Ended December 31, | 
 | 2019 | 2018
Time charter equivalent revenues | $335,133 | $326,707
Add: Voyage expenses | 20,414 | 39,456
Shipping revenues | $355,547 | $366,163


Question: What does TCE revenues represent?
Answer: shipping revenues less voyage expenses, as a measure to compare revenue generated from a voyage charter to revenue generated from a time charter.
The primary components of the deferred tax assets and liabilities are as follows, for the periods indicated below:
We believe that sufficient uncertainty exists regarding the realization of certain deferred tax assets that a valuation allowance is required. We continue to evaluate our taxable position quarterly and consider factors by taxing jurisdiction, including but not limited to factors such as estimated taxable income, any historical experience of losses for tax purposes and the future growth of OpenText.
Table:
 | June 30, | 
 | 2019 | 2018
Deferred tax assets |  | 
Non-capital loss carryforwards | $161,119 | $129,436
Capital loss carryforwards | 155 | 417
Undeducted scientific research and development expenses | 137,253 | 123,114
Depreciation and amortization | 683,777 | 829,369
Restructuring costs and other reserves | 17,845 | 17,202
Deferred revenue | 53,254 | 62,726
Other | 59,584 | 57,461
Total deferred tax asset | $1,112,987 | $1,219,725
Valuation Allowance | $(77,328) | $(80,924)
Deferred tax liabilities |  | 
Scientific research and development tax credits | $(14,482) | $(13,342)
Other | (72,599) | (82,668)
Deferred tax liabilities | $(87,081) | $(96,010)
Net deferred tax asset | $948,578 | $1,042,791
Comprised of: |  | 
Long-term assets | 1,004,450 | 1,122,729
Long-term liabilities | (55,872) | (79,938)
 | $948,578 | $1,042,791


Question: What does the table show?
Answer: primary components of the deferred tax assets and liabilities
item 1b . unresolved staff comments not applicable . item 2 . properties as of december 26 , 2015 , our major facilities consisted of : ( square feet in millions ) united states countries total owned facilities1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30.7 17.2 47.9 leased facilities2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.1 6.0 8.1 .

Table:
( square feet in millions ) | unitedstates | othercountries | total
owned facilities1 | 30.7 | 17.2 | 47.9
leased facilities2 | 2.1 | 6.0 | 8.1
total facilities | 32.8 | 23.2 | 56.0
1 leases on portions of the land used for these facilities expire on varying dates through 2062 .
2 leases expire on varying dates through 2030 and generally include renewals at our option .
our principal executive offices are located in the u.s .
and a majority of our wafer fabrication activities are also located in the u.s .
we completed construction of development fabrication facilities in oregon during 2014 that we expect will enable us to maintain our process technology lead .
we also completed construction of a large-scale fabrication building in arizona in 2013 .
a portion of the new oregon and arizona facilities are currently not in use and we are reserving the new buildings for additional capacity and future technologies .
incremental construction and equipment installation are required to ready the facilities for their intended use .
our massachusetts fabrication facility was our last manufacturing facility on 200mm wafers and ceased production in q1 2015 .
outside the u.s. , we have wafer fabrication facilities in ireland , israel , and china .
our fabrication facility in ireland has transitioned to our 14nm process technology , with manufacturing continuing to ramp in 2016 .
additionally , in the second half of 2016 , we will start using our facility in dalian , china to help expand our manufacturing capacity in next-generation memory .
our assembly and test facilities are located in malaysia , china , and vietnam .
in addition , we have sales and marketing offices worldwide that are generally located near major concentrations of customers .
we believe that the facilities described above are suitable and adequate for our present purposes and that the productive capacity in our facilities is substantially being utilized or we have plans to utilize it .
we do not identify or allocate assets by operating segment .
for information on net property , plant and equipment by country , see 201cnote 26 : operating segments and geographic information 201d in part ii , item 8 of this form 10-k .
item 3 .
legal proceedings for a discussion of legal proceedings , see 201cnote 25 : contingencies 201d in part ii , item 8 of this form 10-k .
item 4 .
mine safety disclosures not applicable. .

Question: what percentage of total facilities as measured in square feet are owned?
Answer: 86%
Calculation: divide(47.9, 56.0)
17. Financial Information About Segments
Our operations are divided into two reportable segments: Products and Licensing and Technology Development. The Products and Licensing segment develops and sells products or licenses technologies based on commercially viable concepts developed by the Technology Development segment. The Products and Licensing segment derives its revenue from product sales, funded product development and technology licenses.
Our engineers and scientists collaborate with our network of government, academic and industry experts to identify technologies and ideas with promising market potential. We then compete to win fee-for-service contracts from government agencies and industrial customers who seek innovative solutions to practical problems that require new technology. The Technology Development segment derives its revenue primarily from services. The Technology Development segment provides applied research to customers in our areas of focus.
Our President and Chief Executive Officer and his direct reports collectively represent our chief operating decision makers, and they evaluate segment performance based primarily on revenue and operating income or loss.
Information about the results of operations for each segment is set forth in the table below. There were no significant inter-segment sales during the years ended December 31, 2019 and 2018.
During the years ended December 31, 2019 and 2018, 32% and 24%, respectively, of our total sales took place outside the United States. Customers in China represented 11% of total revenues in the year ended December 31, 2019, while no other single country, outside of the United States, represented more than 10% of total revenues in the year ended December 31, 2018.
Table:
 | Years ended December 31, | 
 | 2019 | 2018
Products and Licensing revenue | $44,491,041 | $21,949,689
Technology Development revenue | 26,024,674 | 20,967,556
Total revenue | $70,515,715 | $42,917,245
Products and Licensing operating income | $1,807,616 | $499,323
Technology Development operating income  | 1,507,405 | 378,212
Total operating income | $3,315,021 | $877,535
Depreciation, Technology Development | $397,296 | $379,952
Depreciation, Products and Licensing  | $552,285 | $273,185
Amortization, Technology Development  | $91,185 | $130,765
Amortization, Products and Licensing | $1,462,525 | $418,349


Question: What are the two reportable segments of operations?
Answer: Products and Licensing and Technology Development.
stock total return performance the following graph compares our total return to stockholders with the returns of the standard & poor 2019s composite 500 index ( 201cs&p 500 201d ) and the dow jones us select health care providers index ( 201cpeer group 201d ) for the five years ended december 31 , 2014 . the graph assumes an investment of $ 100 in each of our common stock , the s&p 500 , and the peer group on december 31 , 2009 , and that dividends were reinvested when paid. .

Table:
 | 12/31/2009 | 12/31/2010 | 12/31/2011 | 12/31/2012 | 12/31/2013 | 12/31/2014
hum | $ 100 | $ 125 | $ 201 | $ 160 | $ 244 | $ 342
s&p 500 | $ 100 | $ 115 | $ 117 | $ 136 | $ 180 | $ 205
peer group | $ 100 | $ 112 | $ 123 | $ 144 | $ 198 | $ 252
the stock price performance included in this graph is not necessarily indicative of future stock price performance .
table of contents .

Question: what was the percent of the change in the stock price performance for hum from 2010 to 2011
Answer: 60.8%
Calculation: subtract(201, 125), divide(#0, 125)
notes to consolidated financial statements the following table sets forth the activity related to the 2005 restructuring plan liabilities . ( millions ) .

Table:
balance at january 1 2005 | $ 2014
expensed in 2005 | 141
cash payments in 2005 | -23 ( 23 )
foreign currency revaluation | -2 ( 2 )
balance at december 31 2005 | 116
expensed in 2006 | 155
cash payments in 2006 | -141 ( 141 )
foreign currency revaluation | 4
balance at december 31 2006 | 134
expensed in 2007 | 38
cash payments in 2007 | -110 ( 110 )
foreign currency revaluation | 1
balance at december 31 2007 | $ 63
aon 2019s unpaid restructuring liabilities are included in both accounts payable and accrued liabilities and other non-current liabilities in the consolidated statements of financial position .
aon corporation .

Question: what is the net change in aon 2019s unpaid restructuring liabilities during 2006?
Answer: 18
Calculation: add(155, -141), add(#0, 4)
Cost of revenues. Cost of revenues increased by 20% to RMB59,659 million for the fourth quarter of 2019 on a year-on-year basis. The increase was mainly due to greater costs of FinTech services, channel costs and content costs. As a percentage of revenues, cost of revenues decreased to 56% for the fourth quarter of 2019 from 59% for the fourth quarter of 2018. The following table sets forth our cost of revenues by line of business for the fourth quarter of 2019 and the fourth quarter of 2018:
Cost of revenues for VAS increased by 28% to RMB26,120 million for the fourth quarter of 2019 on a year-on-year basis. The increase mainly reflected greater channel costs for smart phone games due to increased revenues, including the channel costs attributable to Supercell, as well as higher content costs for services and products such as live broadcast services, online games and music streaming.
Cost of revenues for FinTech and Business Services increased by 32% to RMB21,520 million for the fourth quarter of 2019 on a year-on-year basis. The increase was primarily driven by scale expansion of our payment-related services and cloud business.
Cost of revenues for Online Advertising decreased by 14% to RMB9,241 million for the fourth quarter of 2019 on a year-on-year basis. The decrease was mainly due to lower content costs for video advertising as a result of fewer major content releases, and to cost management.
Table:
 | Unaudited |  |  | 
 | Three months ended |  |  | 
 | 31 December 2019 |  | 31 December 2018 | 
 |  | % of |  | % of
 |  | segment |  | segment
 | Amount | revenues | Amount | revenues
 |  |  | (Restated) | (Restated)
 | (RMB in millions, unless specified) |  |  | 
VAS | 26,120 | 50% | 20,330 | 47%
FinTech and Business Services | 21,520 | 72% | 16,310 | 76%
Online Advertising | 9,241 | 46% | 10,800 | 63%
Others | 2,778 | 84% | 2,304 | 88%
Total cost of revenues | 59,659 |  | 49,744 | 


Question: What was the percentage increase in cost of FinTech and Business Services revenue between the fourth quarter of 2018 and 2019?
Answer: 32%
17. Financial Information About Segments
Our operations are divided into two reportable segments: Products and Licensing and Technology Development. The Products and Licensing segment develops and sells products or licenses technologies based on commercially viable concepts developed by the Technology Development segment. The Products and Licensing segment derives its revenue from product sales, funded product development and technology licenses.
Our engineers and scientists collaborate with our network of government, academic and industry experts to identify technologies and ideas with promising market potential. We then compete to win fee-for-service contracts from government agencies and industrial customers who seek innovative solutions to practical problems that require new technology. The Technology Development segment derives its revenue primarily from services. The Technology Development segment provides applied research to customers in our areas of focus.
Our President and Chief Executive Officer and his direct reports collectively represent our chief operating decision makers, and they evaluate segment performance based primarily on revenue and operating income or loss.
Information about the results of operations for each segment is set forth in the table below. There were no significant inter-segment sales during the years ended December 31, 2019 and 2018.
During the years ended December 31, 2019 and 2018, 32% and 24%, respectively, of our total sales took place outside the United States. Customers in China represented 11% of total revenues in the year ended December 31, 2019, while no other single country, outside of the United States, represented more than 10% of total revenues in the year ended December 31, 2018.
Table:
 | Years ended December 31, | 
 | 2019 | 2018
Products and Licensing revenue | $44,491,041 | $21,949,689
Technology Development revenue | 26,024,674 | 20,967,556
Total revenue | $70,515,715 | $42,917,245
Products and Licensing operating income | $1,807,616 | $499,323
Technology Development operating income  | 1,507,405 | 378,212
Total operating income | $3,315,021 | $877,535
Depreciation, Technology Development | $397,296 | $379,952
Depreciation, Products and Licensing  | $552,285 | $273,185
Amortization, Technology Development  | $91,185 | $130,765
Amortization, Products and Licensing | $1,462,525 | $418,349


Question: What is the change in Products and Licensing revenue between December 31, 2018 and 2019?
Answer: 22541352
Calculation: 44,491,041-21,949,689
the following table provides certain information as of may 31 , 2014 concerning the shares of the company 2019s common stock that may be issued under existing equity compensation plans . for more information on these plans , see note 11 to notes to consolidated financial statements . plan category number of securities to be issued upon exercise of outstanding options , warrants and rights weighted- average exercise price of outstanding options , warrants and rights number of securities remaining available for future issuance under equity compensation plans ( excluding securities reflected in column ( a ) ) equity compensation plans approved by security holders 766801 $ 40.85 8945694 equity compensation plans not approved by security holders 2014 2014 2014 .

Table:
plan category | number of securities to be issued upon exercise of outstanding options warrants and rights ( a ) | weighted-average exerciseprice of outstanding options warrants and rights ( b ) | number of securitiesremaining available forfuture issuance under equity compensation plans ( excluding securities reflected in column ( a ) ) ( c )
equity compensation plans approved by security holders | 766801 | $ 40.85 | 8945694
equity compensation plans not approved by security holders | 2014 | 2014 | 2014
total | 766801 | $ 40.85 | 8945694
the information presented in the table above includes shares of common stock available for issuance other than upon the exercise of an option , warrant or right under the employee stock purchase plan and the 2011 incentive plan .
in addition , it includes 977296 shares authorized under the amended and restated 2005 incentive plan and 584004 shares authorized under the 2000 long-term incentive plan .
as previously disclosed , we do not intend to issue shares under either the amended and restated 2005 incentive plan or the 2000 long-term incentive plan .
item 13 2014 certain relationships and related transactions , and director independence we incorporate by reference in this item 13 the information regarding certain relationships and related transactions between us and our affiliates and the independence of our directors contained under the headings 201ccertain relationships and related transactions 201d and 201cboard independence 201d from our proxy statement to be delivered in connection with our 2014 annual meeting of shareholders .
item 14 2014principal accounting fees and services we incorporate by reference in this item 14 the information regarding principal accounting fees and services contained under the heading 201cratification of the reappointment of auditors 201d from our proxy statement to be delivered in connection with our 2014 annual meeting of shareholders. .

Question: what is the total value of securities issued and approved by security holders , ( in millions ) ?
Answer: 31.3
Calculation: multiply(766801, 40.85), divide(#0, const_1000000)
shareholder return performance the line graph below compares the annual percentage change in ball corporation fffds cumulative total shareholder return on its common stock with the cumulative total return of the dow jones containers & packaging index and the s&p composite 500 stock index for the five-year period ended december 31 , 2012 . it assumes $ 100 was invested on december 31 , 2007 , and that all dividends were reinvested . the dow jones containers & packaging index total return has been weighted by market capitalization . total return to stockholders ( assumes $ 100 investment on 12/31/07 ) total return analysis .

Table:
 | 12/31/2007 | 12/31/2008 | 12/31/2009 | 12/31/2010 | 12/31/2011 | 12/31/2012
ball corporation | $ 100.00 | $ 93.28 | $ 117.01 | $ 155.14 | $ 164.09 | $ 207.62
dj us containers & packaging | $ 100.00 | $ 61.55 | $ 84.76 | $ 97.78 | $ 96.27 | $ 107.76
s&p 500 | $ 100.00 | $ 61.51 | $ 75.94 | $ 85.65 | $ 85.65 | $ 97.13
source : bloomberg l.p .
aecharts .

Question: the five year total return for the period ending 12/31/2012 on ball corporation stock was how much greater than the same return on the dj us containers & packaging index?
Answer: 110.49
Calculation: subtract(207.62, 97.13)
S. Selected Quarterly Financial Data (unaudited)
Quarterly financial data for fiscal 2020 and 2019 were as follows (tables in millions, except per share amounts):
(1) Adjusted to reflect the recast of prior period information due to the Pivotal acquisition, which was accounted for as a transaction between entities under common control (refer to Note B).
Table:
Fiscal 2020 | Q1 2020 (1) | Q2 2020 (1) | Q3 2020 (1) | Q4 2020
Total revenue | $2,450 | $2,632 | $2,656 | $3,073
Net income attributable to VMware, Inc. | 380 | 5,303 | 407 | 321
common stockholders, basic for Classes A and B Net income per weighted-average share attributable to VMware, Inc. common stockholders, basic for Classes A and B | $0.91 | $12.72 | $0.98 | $0.77
Net income per weighted-average share attributable to VMware, Inc. common stockholders, diluted for Classes A and B | $0.89 | $12.47 | $0.96 | $0.76


Question: What was the total revenue in Q1 2020?
Answer: 2,450
ADVANCED ENERGY INDUSTRIES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (continued) (in thousands, except per share amounts)
NOTE 10. INVENTORIES
Our inventories are valued at the lower of cost or net realizable value and computed on a first-in, first-out (FIFO) basis. Components of inventories are as follows:
Table:
 | December 31, | 
 | 2019 | 2018
Parts and raw materials | $134,816 | $76,647
Work in process | 10,269 | 6,644
Finished goods | 84,934 | 14,696
Total | $230,019 | $97,987


Question: What were the inventories of work in progress in 2018?
Answer: 6,644
The following table summarizes the components of net periodic pension cost recognized in the consolidated statements of operations for the plans for the years ended December 31, 2019, 2018 and 2017:
The components of net periodic pension cost other than the service cost component are included in other, net within other income (expense) in the consolidated statements of operations.
In 2019, we purchased a group annuity contract to transfer the pension benefit obligations and annuity administration for a select group of retirees or their beneficiaries to an annuity provider. Upon issuance of the group annuity contract, the pension benefit obligation of $24.4 million for approximately 500 participants was irrevocably transferred to the annuity provider. The purchase of the group annuity was funded directly by the assets of the Pension Plans. During the year ended December 31, 2019, we recognized a pension settlement charge of $6.7 million as a result of the transfer of the pension liability to the annuity provider and other lump sum payments made during the year.
In 2018 and 2017, the Retirement Plan was amended to freeze benefit accruals under the cash balance benefit plan for certain participants under collective bargaining agreements. As a result of these amendments, we recognized a pre-tax curtailment gain of $1.2 million and $1.3 million as a component of net periodic pension cost during the years ended December 31, 2018 and 2017, respectively.
Table:
(In thousands) | 2019 | 2018 | 2017
Service cost | $ 50 | $ 5,809 | $ 3,055
Interest cost | 30,327 | 28,870 | 21,882
Expected return on plan assets | (34,627) | (38,640) | (28,459)
Amortization of: |  |  | 
Net actuarial loss | 2,890 | 6,110 | 6,244
Prior service cost (credit) | 123 | (204) | (316)
Plan curtailment | — | (1,156) | (1,337)
Plan settlement | 6,726 | 94 | 17
Net periodic pension cost | $ 5,489 | $ 883 | $ 1,086


Question: What was the average interest cost for 2017-2019?
Answer: 27026.33
Calculation: (30,327 + 28,870 + 21,882) / 3
(1) Mr. Clark did not receive a FY19 EAIP payout.
(2) Pursuant to the terms of Mr. Noviello’s Transition Services Agreement dated January 31, 2019 (the ‘‘Transition Services Agreement’’), Mr. Noviello received 75% of his target FY19 EAIP amount under the Company’s Executive Severance Plan because it was greater than the amount that he would have earned under the FY19 EAIP irrespective of individual performance.
(3) Ms. Cappellanti-Wolf and Messrs. Kapuria and Taylor each earned an individual performance factor of 100%. In determining the appropriate individual performance factor for each of these executives, the Compensation Committee, with recommendation of the CEO, considered leadership, contributions to NortonLifeLock’s achievement of its goals, and strategic planning among other factors.
(4) The Compensation Committee did not exercise its discretion to reduce any payouts.
Table:
 | FY19 EAIP NEO Payout Amounts |  |  |  | 
NEO | Base Salary | Annual Incentive Target (%) | Company Performance Funding (%) | Individual Performance Factor (%) | Individual Payout Amount ($)(4)
Gregory S. Clark(1) | 1,000,000 | 150 | n/a | n/a | 0
Nicholas R. Noviello(2) | 650,000 | 100 | n/a | n/a | 487,500
Amy L. Cappellanti-Wolf(3) | 440,000 | 70 | 35.6 | 100 | 109,648
Samir Kapuria(3) | 450,000 | 100 | 35.6 | 100 | 152,172
Scott C. Taylor(3) | 600,000 | 100 | 35.6 | 100 | 213,600


Question: Who did not recieve a FY19 EAIP payout?
Answer: Mr. Clark